134 related articles for article (PubMed ID: 27724971)
1. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
Theotokis P; Touloumi O; Lagoudaki R; Nousiopoulou E; Kesidou E; Siafis S; Tselios T; Lourbopoulos A; Karacostas D; Grigoriadis N; Simeonidou C
J Neuroinflammation; 2016 Oct; 13(1):265. PubMed ID: 27724971
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.
Aarts SABM; Seijkens TTP; Kusters PJH; van der Pol SMA; Zarzycka B; Heijnen PDAM; Beckers L; den Toom M; Gijbels MJJ; Boon L; Weber C; de Vries HE; Nicolaes GAF; Dijkstra CD; Kooij G; Lutgens E
J Neuroinflammation; 2017 May; 14(1):105. PubMed ID: 28494768
[TBL] [Abstract][Full Text] [Related]
4. Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
Zilkha-Falb R; Kaushansky N; Kawakami N; Ben-Nun A
J Neuroinflammation; 2016 Jan; 13():7. PubMed ID: 26747276
[TBL] [Abstract][Full Text] [Related]
5. Ginger extracts influence the expression of IL-27 and IL-33 in the central nervous system in experimental autoimmune encephalomyelitis and ameliorates the clinical symptoms of disease.
Jafarzadeh A; Mohammadi-Kordkhayli M; Ahangar-Parvin R; Azizi V; Khoramdel-Azad H; Shamsizadeh A; Ayoobi A; Nemati M; Hassan ZM; Moazeni SM; Khaksari M
J Neuroimmunol; 2014 Nov; 276(1-2):80-8. PubMed ID: 25175065
[TBL] [Abstract][Full Text] [Related]
6. Copper-zinc superoxide dismutase-deficient mice show increased susceptibility to experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein 35-55.
Massilamany C; Gangaplara A; Kim H; Stanford C; Rathnaiah G; Steffen D; Lee J; Reddy J
J Neuroimmunol; 2013 Mar; 256(1-2):19-27. PubMed ID: 23294897
[TBL] [Abstract][Full Text] [Related]
7. Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis.
Borjini N; Fernández M; Giardino L; Calzà L
J Neuroinflammation; 2016 Nov; 13(1):291. PubMed ID: 27846891
[TBL] [Abstract][Full Text] [Related]
8. Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis.
Hassen GW; Feliberti J; Kesner L; Stracher A; Mokhtarian F
Brain Res; 2008 Oct; 1236():206-15. PubMed ID: 18725211
[TBL] [Abstract][Full Text] [Related]
9. VISTA expression by microglia decreases during inflammation and is differentially regulated in CNS diseases.
Borggrewe M; Grit C; Den Dunnen WFA; Burm SM; Bajramovic JJ; Noelle RJ; Eggen BJL; Laman JD
Glia; 2018 Dec; 66(12):2645-2658. PubMed ID: 30306644
[TBL] [Abstract][Full Text] [Related]
10. Histopatological parameters of the spinal cord in different phases of experimental autoimmune encephalomyelitis. A mouse model of multiple sclerosis examined by classical stainings combined with immunohistochemistry.
Pyka-Fosciak G; Fosciak M; Wojcik B; Lis GJ; Litwin JA
J Physiol Pharmacol; 2023 Aug; 74(4):. PubMed ID: 37865962
[TBL] [Abstract][Full Text] [Related]
11. Expression of purinergic P2X7 receptor in rat brain during the symptomatic phase of experimental autoimmune encephalomyelitis and after recovery of neurological deficits.
Grygorowicz T; Sulejczak D; Struzynska L
Acta Neurobiol Exp (Wars); 2011; 71(1):65-73. PubMed ID: 21499327
[TBL] [Abstract][Full Text] [Related]
12. Gender effect on neurodegeneration and myelin markers in an animal model for multiple sclerosis.
Massella A; D'Intino G; Fernández M; Sivilia S; Lorenzini L; Giatti S; Melcangi RC; Calzà L; Giardino L
BMC Neurosci; 2012 Jan; 13():12. PubMed ID: 22272832
[TBL] [Abstract][Full Text] [Related]
13. Nogo-A antibody delivery through the olfactory mucosa mitigates experimental autoimmune encephalomyelitis in the mouse CNS.
Pernet V; Joly S; Spiegel S; Meli I; Idriss S; Maigler F; Mdzomba JB; Roenneke AK; Franceschini A; Silvestri L; Pavone FS; Calamai M; Schindowski K; Chan A
Cell Death Discov; 2023 Aug; 9(1):290. PubMed ID: 37558696
[TBL] [Abstract][Full Text] [Related]
14. Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS.
Teuscher C; Subramanian M; Noubade R; Gao JF; Offner H; Zachary JF; Blankenhorn EP
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10146-51. PubMed ID: 17548817
[TBL] [Abstract][Full Text] [Related]
15. Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2.
Rodriguez CM; Bechek SC; Jones GL; Nakayama L; Akiyama T; Kim G; Solow-Cordero DE; Strittmatter SM; Gitler AD
Cell Rep; 2022 Oct; 41(4):111505. PubMed ID: 36288715
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune demyelination alters hypothalamic transcriptome and endocrine function.
Carver JJ; Lau KM; Puckett AE; Didonna A
J Neuroinflammation; 2024 Jan; 21(1):12. PubMed ID: 38178091
[TBL] [Abstract][Full Text] [Related]
17. Lipid metabolism is dysregulated in endocrine glands upon autoimmune demyelination.
Carver JJ; Pugh BA; Lau KM; Didonna A
J Neuroimmunol; 2024 Jun; 391():578366. PubMed ID: 38733741
[TBL] [Abstract][Full Text] [Related]
18. Rapid quantification of inflammation in tissue samples using perfluorocarbon emulsion and fluorine-19 nuclear magnetic resonance.
Ahrens ET; Young WB; Xu H; Pusateri LK
Biotechniques; 2011 Apr; 50(4):229-34. PubMed ID: 21548906
[TBL] [Abstract][Full Text] [Related]
19. Axonopathy in the Central Nervous System Is the Hallmark of Mice with a Novel Intragenic Null Mutation of Dystonin.
Seehusen F; Kiel K; Jottini S; Wohlsein P; Habierski A; Seibel K; Vogel T; Urlaub H; Kollmar M; Baumgärtner W; Teichmann U
Genetics; 2016 Sep; 204(1):191-203. PubMed ID: 27401753
[TBL] [Abstract][Full Text] [Related]
20. Nogo-A is secreted in extracellular vesicles, occurs in blood and can influence vascular permeability.
Rust R; Holm MM; Egger M; Weinmann O; van Rossum D; Walter FR; Santa-Maria AR; Grönnert L; Maurer MA; Kraler S; Akhmedov A; Cideciyan R; Lüscher TF; Deli MA; Herrmann IK; Schwab ME
J Cereb Blood Flow Metab; 2024 Jun; 44(6):938-954. PubMed ID: 38000040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
